At a glance
The March 20, 2023, Laboratory Outreach Communication System (LOCS) call included updates on the Marburg virus disease, SARS-CoV-2 variants, FDA, and the use of the Laboratory Preparedness Exercise (LPX) to assess the rule-out/referral capability of clinical laboratories.
Agenda
Welcome: Sean Courtney, CDC Division of Laboratory Systems
Marburg Virus Disease Update: Joel Montgomery, CDC Division of High Consequence Pathogens and Pathology
SARS-CoV-2 Variants Update: Natalie Thornburg, CDC Coronavirus and Other Respiratory Viruses Division
FDA Update: Timothy Stenzel, U.S. Food and Drug Administration
Use of Laboratory Preparedness Exercise (LPX) to Assess Rule-Out/Referral Capability of Clinical Laboratories: Chris N. Mangal, Association of Public Health Laboratories